TROKENDI XR Trademark

Trademark Overview

On Wednesday, June 6, 2012, a trademark application was filed for TROKENDI XR with the United States Patent and Trademark Office. The USPTO has given the TROKENDI XR trademark a serial number of 85644722. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, December 17, 2024. This trademark is owned by Supernus Pharmaceuticals, Inc.. The TROKENDI XR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations or substances for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders
trokendi xr

General Information

Serial Number85644722
Word MarkTROKENDI XR
Filing DateWednesday, June 6, 2012
Status800 - REGISTERED AND RENEWED
Status DateTuesday, December 17, 2024
Registration Number4498773
Registration DateTuesday, March 18, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 11, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations or substances for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders
NOT AVAILABLE"XR"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 19, 2012
Primary Code005
First Use Anywhere DateMonday, September 30, 2013
First Use In Commerce DateMonday, September 30, 2013

Trademark Owner History

Party NameSupernus Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameSupernus Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameSupernus Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Tuesday, June 19, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 9, 2012NEW APPLICATION ENTERED
Friday, November 2, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, September 22, 2012ASSIGNED TO EXAMINER
Tuesday, September 25, 2012NON-FINAL ACTION WRITTEN
Tuesday, September 25, 2012NON-FINAL ACTION E-MAILED
Tuesday, September 25, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 18, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 18, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 18, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 19, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 2, 2012ASSIGNED TO LIE
Monday, July 29, 2013SOU TEAS EXTENSION RECEIVED
Monday, July 29, 2013SOU EXTENSION 1 FILED
Monday, July 29, 2013SOU EXTENSION 1 GRANTED
Thursday, December 12, 2013USE AMENDMENT FILED
Friday, January 24, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 21, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 11, 2012PUBLISHED FOR OPPOSITION
Tuesday, December 11, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 5, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 31, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 12, 2013TEAS STATEMENT OF USE RECEIVED
Friday, January 31, 2014STATEMENT OF USE PROCESSING COMPLETE
Monday, February 10, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 11, 2014LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, February 12, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 18, 2014REGISTERED-PRINCIPAL REGISTER
Monday, March 18, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, March 18, 2020TEAS SECTION 8 & 15 RECEIVED
Saturday, May 9, 2020POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Saturday, May 9, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, May 13, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, November 9, 2020TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, November 11, 2020POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Wednesday, November 18, 2020TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, May 13, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, December 16, 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, December 17, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, March 18, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, March 18, 2024TEAS SECTION 8 & 9 RECEIVED
Tuesday, June 18, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 18, 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Tuesday, December 17, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, December 17, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

trokendi diseases disorders system nervous preparations psychiatric neurological substances peripheral central